Binnert C, Ruchat S, Nicod N, Tappy L
Département de physiologie, 7, rue du Bugnon, 1005 Lausanne, Suisse.
Diabetes Metab. 2004 Sep;30(4):321-6. doi: 10.1016/s1262-3636(07)70123-4.
Recent reports suggest that lipid-induced insulin resistance is more pronounced in men than in women. Whether such gender difference exists for other factors known to induce insulin resistance in healthy individuals remains unknown. We therefore assessed whether glucocorticoid-induced insulin resistance differs in men and women.
The insulin sensitivity and insulin secretion of 8 women and 7 men, all non obese and healthy, were evaluated with or without administration of dexamethasone (2 mg/day during 2 days) by means of a two-step hyperglycemic clamp.
Dexamethasone decreased insulin sensitivity to the same extent in men and women. The relative increases in insulin concentration observed after dexamethasone in the basal state, during the first phase of insulin release and at the two steps of hyperglycemia were similar in men and women. The hyperinsulinemia thus attained allowed to fully compensate for insulin resistance in both genders.
The effects of glucocorticoids on insulin sensitivity and insulin secretion show no gender difference in healthy humans.
近期报告表明,脂质诱导的胰岛素抵抗在男性中比在女性中更为明显。对于已知在健康个体中诱导胰岛素抵抗的其他因素,这种性别差异是否存在仍不清楚。因此,我们评估了糖皮质激素诱导的胰岛素抵抗在男性和女性中是否存在差异。
通过两步高血糖钳夹法,对8名女性和7名男性(均非肥胖且健康)在给予或不给予地塞米松(2毫克/天,持续2天)的情况下,评估其胰岛素敏感性和胰岛素分泌。
地塞米松在男性和女性中降低胰岛素敏感性的程度相同。在基础状态、胰岛素释放的第一阶段以及高血糖的两个步骤中,地塞米松给药后观察到的胰岛素浓度相对增加在男性和女性中相似。由此产生的高胰岛素血症能够完全补偿两性中的胰岛素抵抗。
在健康人群中,糖皮质激素对胰岛素敏感性和胰岛素分泌的影响不存在性别差异。